Policy & Regulation
SciBase research highlights Nevisense potential in age-related skin analysis
18 May 2026 -

SciBase Holding AB (STO: SCIB), a developer of AI-based diagnostic solutions for skin disorders, announced on Monday that new research presented at the Society for Investigative Dermatology Annual Meeting showed that its Nevisense platform can detect and quantify age-related skin barrier changes using proprietary Electrical Impedance Spectroscopy technology.

The study, conducted by Professor Abuabara and Dr. Zhu at University of California, San Francisco, compared EIS measurements between younger adults with a mean age of 25.9 years and older adults with a mean age of 79.1 years.

Researchers analysed 700 parameters from each Nevisense measurement and developed a composite barrier score that identified 35 age-associated EIS features in the forearm. The score demonstrated a strong correlation with age, with a Spearman rho of 0.69, indicating the technology can detect subtle changes in skin architecture and composition linked to ageing.

The study also found that analysing specific EIS features provided a more sensitive assessment of age-related skin barrier changes than standard summary values.

SciBase said the findings expand Nevisense's potential applications beyond melanoma detection and atopic dermatitis assessment into geriatric dermatology and longevity science. The company said further validation studies are planned to refine the composite barrier score for clinical and research use.

Login
Username:

Password: